Syndromic genetic keratoconus Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

2Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Syndromic genetic keratoconus.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance2

Photrexa Viscous

Glaukos Corporation

OpenContact for details

Epioxa HD and Epioxa

Glaukos Corporation

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Epioxa HD and Epioxa

(riboflavin 5'-phosphate)Orphan drug

Glaukos Corporation

12.1 Mechanism of Action Riboflavin 5'-phosphate sodium (Vitamin B2) is the precursor of two coenzymes, flavin adenine dinucleotide and flavin mononuc...

Approved Oct 2025FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Syndromic genetic keratoconus.
Search all trials →

Search clinical trials for Syndromic genetic keratoconus →

Recent News & Research

No recent news articles indexed yet for Syndromic genetic keratoconus.
Search PubMed for Syndromic genetic keratoconus →

Browse all Syndromic genetic keratoconus news →

Specialist Network

No specialists currently listed for Syndromic genetic keratoconus.

View all Syndromic genetic keratoconus specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰